Injective ETF Lands on Nasdaq as INJ Price Surges 22%

INJ is testing a key Fibonacci resistance after a sharp rebound from its early November low. Nasdaq approved the listing of Canary Capital’s Staked INJ ETF. The fund stakes most of its INJ, but fees take a large share of the rewards. An overbought RSI and an unresolved death cross leave the rally unconfirmed. The first Injective ETF in the US has won Nasdaq listing approval , and INJ has climbed roughly 22% since bottoming at $6.82 on November 3 to trade near $8.30 on Thursday.

Source: Crypto News Flash